Durable Responses Achieved in Patients with MYC-Altered Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated with Fimepinostat (CUDC-907): Combined Results from a Phase 1 and Phase 2 Study
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2018）
关键词
CUDC-907,DLBCL,MYC,HDAC,PI3K
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要